Prostaglandin E1 for preventing the progress of pulmonary arterial hypertension in rat model

Pulmonary artery hypertension (PAH) is a progressive chronic disease with a high mortality rate. Increased pulmonary vascular resistance and over-proliferation of pulmonary artery endothelial cells lead to remodeling of pulmonary vasculature. Several anti-PAH therapies targeting various pathways inv...

Full description

Bibliographic Details
Main Authors: Jae Chul Lee, Soo Young Choe, Chan Yeong Heo, Sun Ju Jeong
Format: Article
Language:English
Published: Atlantis Press 2018-05-01
Series:Artery Research
Subjects:
Online Access:https://www.atlantis-press.com/article/125924946/view